๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Closing remarks

โœ Scribed by Donna F. Stroup


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
34 KB
Volume
18
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

โœฆ Synopsis


We should acknowledge the role that Dr. Colton has played in these symposia since their inauguration in 1988. It was through his vision that the "rst of these symposia was held. The proceedings from this conference will mark the 10th anniversary of the collaboration of CDC and Statistics in Medicine, published by John Wiley & Sons. His support, encouragement, and constant urging to quality and timely publication have greatly a!ected the creation and dissemination of the results of these symposia.

Secondly, I thank Ken Falter and his Deputy Chair, Don Betts, for a most commendable symposium. They, along with their excellent sta!, have produced a stimulating and valuable conference. Donald and Ken, I welcome you now to the distinguished society of past chairs of CDC/ATSDR statistical symposia.

To summarize the conference, I used an exploratory data analytic approach. A pattern emerged, and in honour of Dr. Colton, who could not be with us for the "rst time ever in this series, we call these the &C' concepts. The "rst concept that I saw emerging from the talks and the posters is completeness. The "rst symposium in 1988 was a symposium on statistics and surveillance. It was held at CDC and approximately 100 people came together and presented about 25 papers. The topic of surveillance was chosen since it was and remains a core public health function. The purpose of the "rst symposium was to bring to one of the core public health functions the science of statistics and begin to illustrate how statistics can bring an important piece of evidence to that activity. Still in this conference we see statisticians dealing with issues relating to surveillance. We heard about analysis of aberrations, quality control charts from industry, cluster analyses, and Bayesian methods of surveillance analysis.

We have learned much since that "rst symposium. In 1997, we have approximately three times the number of attendees from academia, industry and international countries. We have representation from 28 states and nine international countries. As a colleague of mine said recently &So, 300 of your closest friends are coming to town tomorrow, right?' The second symposium had to do with cluster analyses, and we heard about clusters again at this symposium (for example, Dr. Chen's paper on q-statistics and the last parallel session on geographical smoothing and spatial analysis).

The topic of the third symposium on the evaluation of intervention and prevention strategies was revisited here when we heard about the evaluation of hepatitis B immunization programmes and the evaluation of control measures for a measles outbreak. The fourth symposium on the combination of data from multiple sources was recalled by a meta-analysis of educational and intervention activities in schools. And "nally, the last symposium on geographical information systems concerned methods used in the plenary session on spatial statistics.


๐Ÿ“œ SIMILAR VOLUMES


Closing Remarks
โœ G. Donald Whedon; Alan F. Hofmann ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB
Closing remarks
โœ Roy Schwarz, M. ๐Ÿ“‚ Article ๐Ÿ“… 1969 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB
Closing remarks before the banquet or fr
โœ Satir, Peter ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Wiley (John Wiley & Sons) โš– 318 KB

In a spectacular setting with splendid weather, the 70 or so participants from nearly a dozen nations at the International Congress on Ciliary Motility and Mucociliary Transport set out to encircle a central pair of questions: 1) How precisely do cilia function to move mucus in the mammalian and hum

Progress in the prevention and control o
โœ Mario Rizzetto; Alessandro R. Zanetti ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB

## Abstract Hepatitis type B remains an important disease globally. Rapid advances have been made during the last two decades in the understanding of the biology of HBV, the complex interaction between the virus and the host, and the pathology and the clinical aspects of infection. Mass vaccination